GlassScriptPhysician profile
Marcy M Aldrich
NPI 1346861788
$822.34
in general payments reported to CMS, 2019-2025
16 companies · $99.95 in 2025
The $99.95 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $258 · 2023: $128 · 2024: $120 · 2025: $99.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $177.70 | 2021-2023 | |
| Daiichi Sankyo INC. | $109.14 | 2024-2025 | Injectafer |
| Coopersurgical, INC. | $79.67 | 2022-2023 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $62.20 | 2022-2025 | |
| Dexcom, INC. | $62.19 | 2023-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $60.37 | 2021-2023 | Wegovy |
| Agile Therapeutics, INC. | $51.31 | 2021 | |
| Myovant Sciences INC. | $45.28 | 2022 | |
| Exeltis, USA INC. | $31.14 | 2021-2025 | Slynd |
| Pfizer INC. | $28.18 | 2022 | |
| Biogen, INC. | $22.73 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $21.05 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $19.22 | 2022 | |
| Shield Therapeutics INC | $17.69 | 2023 | Accrufer |
| Sumitomo Pharma America, INC. | $17.66 | 2023 | Myfembree |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $16.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcy Aldrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.